SEC Form 4Coverage since May 26, 2026
$RAPP insider trading
Over the last 12 months, Rapport Therapeutics insiders reported no purchases and 5 sales totaling $1.9M across SEC Form 4 filings. 100% of the activity was filed under pre-arranged 10b5-1 trading plans.
- Bought · 12m
- — 0 events
- Sold · 12m
- $1.9M 5 events
- Events · 12m
- 5 Form 4 filings, grouped
- Insiders · 12m
- 3 distinct reporters
- 10b5-1 share
- 100% pre-arranged plans
Side
Price · $RAPP · 12Mvia TradingView
Top insiders · 12m
Ceesay AbrahamChief Executive Officer3× · $749K
Gault CherylChief Operating Officer1× · $416K
Third Rock Ventures V, L.P.—1× · $744K
All insider trades
5 events
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| Jul 27, 2026 | Ceesay AbrahamChief Executive Officer · O·D | ▼ Sale | 2,210 | $42.11 | $93K | -0.4% | plan · 2 tranches |
| Jul 14, 2026 | Ceesay AbrahamChief Executive Officer · O·D | ▼ Sale | 8,210 | $40 | $328K | -1.5% | plan · 2 tranches |
| Jun 30, 2026 | Gault CherylChief Operating Officer · O | ▼ Sale | 10,000 | $41.58 | $416K | -6.3% | plan · 4 tranches |
| Jun 29, 2026 | Ceesay AbrahamChief Executive Officer · O·D | ▼ Sale | 8,220 | $39.83 | $327K | -1.5% | plan · 2 tranches |
| May 26, 2026 | Third Rock Ventures V, L.P.10% | ▼ Sale | 18,572 | $40.05 | $744K | -0.3% | plan |
About Form 4
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $RAPP feed.